ETRA
Electra Therapeutics Inc. · NASDAQ:ETRA
7.30 USD−0.8000 −9.88%
Electra Therapeutics Inc. (NASDAQ:ETRA) last traded at 7.30 USD, down 9.88% on the day. Over the past year the stock is down 51.33%. Its 52-week range is 7.21 to 15.50. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open8.14
Day range7.21 – 8.38
52-week range7.21 – 15.50
Volume131.87 K
Average volume (10 days)160.84 K
Market cap458.20 M
Dividend yield0.00%
Beta (1 year)−3.40
Performance
−18.71%1 week
−32.09%1 month
−51.33%3 months
−51.33%6 months
−51.33%Year to date
−51.33%1 year
Technical reading
Strongly bearish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Electra Therapeutics Initiated at Buy by HC Wainwright & Co.Dow Jones Newswires · 26 Oct 2026
- Electra Therapeutics Initiated at Overweight by JP MorganDow Jones Newswires · 22 Oct 2026
- Electra Therapeutics Initiated at Buy by JefferiesDow Jones Newswires · 13 Oct 2026
- Electra Therapeutics Initiated at Outperform by Evercore ISI GroupDow Jones Newswires · 13 Oct 2026
- Electra Therapeutics Initiated at Buy by TD CowenDow Jones Newswires · 13 Oct 2026
- Electra Therapeutics Initiated at Overweight by Cantor FitzgeraldDow Jones Newswires · 13 Oct 2026
- OrbiMed Advisors Discloses Investment at Electra Therapeutics with 11.0% StakeTradingView · 25 Sep 2026
- ADARx Pharmaceuticals shares soar in Nasdaq debut after upsized IPOReuters · 25 Sep 2026
Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.